Taiwan Semiconductor vs. ASML: Which Semiconductor Titan Is the Better Buy Today?

The article highlights a 2026 surge with TSMC up 42% and ASML up 76%, but argues the better buy is Taiwan Semiconductor (TSMC) due to valuation and growth expectations. Wall Street is cited expecting 34% growth for TSMC in the next year versus 26% for ASML, while ASML’s forward multiple is described as “parabolic” and expensive. Net-net: ASML’s EUV lithography monopoly is acknowledged, but the piece favors TSMC as the more attractive risk/reward for outperforming into 2027.

Analysis

The cleaner relative trade is not “chip demand up,” it’s who controls the bottleneck. TSM has the more durable earnings path because every AI node transition still flows through its wafer starts, packaging, and yield leadership; that makes it the cleaner beneficiary of incremental OEM/ hyperscaler spend. By contrast, ASML’s economics are exposed to customer capex timing: one or two quarters of digestion at TSM/Samsung/Intel can cause order volatility that the market often misreads as structural slowdown.

The second-order loser set is broader than the article implies. Samsung Foundry and Intel Foundry remain the obvious share-takers if TSM ever stumbles, but the real risk is that their persistent yield gap keeps the industry’s pricing power concentrated with TSM longer than consensus expects. On the supplier side, AMAT/LRCX/KLAC can outperform even if ASML is range-bound, because the market tends to rotate to semi-cap names with a shorter order-to-revenue bridge when lithography multiples get stretched.

The consensus seems to be underpricing geopolitical duration risk for TSM while overpricing the durability of ASML’s monopoly premium. TSM’s multiple can stay cheap for a long time if Taiwan risk remains a headline overhang; that makes valuation a weak standalone catalyst. ASML’s setup is more fragile over 1-3 months if EUV order growth decelerates, because the stock already discounts perfection and has less room for a miss than TSM.

For the next 3-6 months, the best path is relative-value, not outright beta. If TSM keeps printing utilization and advanced-node demand without major guidance cuts, the stock can outperform ASML even if both rise; if ASML order intake softens, the spread should widen quickly. The thesis breaks if TSM guidance turns cautious on CoWoS/advanced packaging or if ASML reports a reacceleration in net bookings that re-rates the monopoly premium higher.

Key Decisions for Investors

• Long TSM / short ASML as a 3-6 month relative-value pair: thesis is TSM deserves a discount to the market, not to ASML; target 10-15% spread move if ASML orders stay lumpy and TSM guidance remains firm.
• If owning semis outright, prefer TSM over ASML on pullbacks: TSM is the cleaner operating leverage play to AI wafer demand; ASML is more exposed to capex timing and valuation compression. Reassess if TSM trades through a meaningful Taiwan-risk discount without fundamental deterioration.
• Use ASML as a tactical hedge against a broader AI hardware pause rather than a core long: buy only if bookings inflect or the multiple resets materially lower; otherwise the risk/reward is poor near peak sentiment.
• Watch AMAT/LRCX/KLAC as secondary beneficiaries: if the market rotates away from rich lithography multiples into cheaper equipment names, these can outperform on a 1-2 quarter horizon even without a change in end-demand.
• Falsifier alert: if TSM advanced-node or CoWoS guidance is cut, exit the long/short relative-value view immediately; if ASML net bookings re-accelerate for two consecutive quarters, the short leg is likely wrong.